Morphological and immunohistochemical characteristics of triple negative and basal breast carcinoma

No abstract is available for this paper.

• Publication year

  2012

• Venue

  Egyptian Journal of Pathology

• Publication date

  2012-07-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/01.XEJ.0000417553.95276.37
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Prevalence, morphologic features and proliferation indices of breast carcinoma molecular classes using immunohistochemical surrogate markers.

  2009influential reference
• Basal carcinoma of the breast revisited: an old entity with new interpretations

  2008cited by this paper
• Basal-like breast cancer: a critical review.

  2008cited by this paper
• Impact of Basal-Like Breast Carcinoma Determination for a More Specific Therapy

  2008influential reference
• Basal-Like Breast Cancer Defined by Five Biomarkers Has Superior Prognostic Value than Triple-Negative Phenotype

  2008cited by this paper
• Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity

  2007cited by this paper
• The basal subtype of breast carcinomas may represent the group of breast tumors that could benefit from EGFR-targeted therapies.

  2007cited by this paper
• Is ‘Basal-Like’ Carcinoma of the Breast a Distinct Clinicopathological Entity? A Critical Review with Cautionary Notes

  2007cited by this paper
• Are triple-negative tumours and basal-like breast cancer synonymous? Authors' response

  2007cited by this paper
• Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas)

  2007influential reference
• Basal-like grade III invasive ductal carcinoma of the breast: patterns of metastasis and long-term survival

  2007cited by this paper
• Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas

  2007influential reference
• Use of immunohistochemical markers can refine prognosis in triple negative breast cancer

  2007cited by this paper
• Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation

  2006cited by this paper
• Ductal carcinoma in situ with basal-like phenotype: a possible precursor to invasive basal-like breast cancer

  2006cited by this paper
• "Basal-like" Breast Carcinomas: Identification by P-cadherin, P63 and EGFR Basal Cytokeratins Expression

  2006influential reference
• Characterization of Familial Non-BRCA1/2 Breast Tumors by Loss of Heterozygosity and Immunophenotyping

  2006cited by this paper
• Phenotypic evaluation of the basal-like subtype of invasive breast carcinoma

  2006influential reference
• Cytokeratin 5/14-positive breast cancer: true basal phenotype confined to BRCA1 tumors

  2005cited by this paper
• Inhibitors of growth factor signalling.

  2005cited by this paper
• Basal cytokeratins and their relationship to the cellular origin and functional classification of breast cancer

  2005cited by this paper
• How to best classify breast cancer: conventional and novel classifications (review).

  2005cited by this paper
• Typical medullary breast carcinomas have a basal/myoepithelial phenotype

  2005cited by this paper
• Correlation of KIT and EGFR overexpression with invasive ductal breast carcinoma of the solid‐tubular subtype, nuclear grade 3, and mesenchymal or myoepithelial differentiation

  2005cited by this paper
• Re: Germline BRCA1 Mutations and a Basal Epithelial Phenotype in Breast Cancer

  2004cited by this paper
• Immunohistochemical and Clinical Characterization of the Basal-Like Subtype of Invasive Breast Carcinoma

  2004influential reference
• Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer.

  2004influential reference
• Hallmarks of 'BRCAness' in sporadic cancers

  2004cited by this paper
• The Prognostic Implication of the Basal-Like (Cyclin Ehigh/p27low/p53+/Glomeruloid-Microvascular-Proliferation+) Phenotype of BRCA1-Related Breast Cancer

  2004cited by this paper
• Breast cancer classification and prognosis based on gene expression profiles from a population-based study

  2003cited by this paper
• A subset of morphologically distinct mammary myoepithelial cells lacks corresponding immunophenotypic markers

  2003cited by this paper
• The importance of being a myoepithelial cell

  2002cited by this paper
• Ductal invasive G2 and G3 carcinomas of the breast are the end stages of at least two different lines of genetic evolution

  2001cited by this paper
• Molecular classification of breast cancer patients by gene expression profiling *

  2001cited by this paper
• Molecular portraits of human breast tumours

  2000influential reference
• Myoepithelial differentiation in high-grade invasive ductal carcinomas with large central acellular zones.

  1999cited by this paper
• Prognostic and predictive factors in breast cancer by immunohistochemical analysis.

  1998cited by this paper
• College of American Pathologists Conference XXVI on clinical relevance of prognostic markers in solid tumors. Summary. Members of the Cancer Committee.

  1995cited by this paper
• Histopathology of myoepithelial (basocellular) hyperplasias in adenosis and epitheliosis of the breast demonstrated by the reactivity of cytokeratins and S100 protein

  1992cited by this paper
• A comparative study of the peroxidase-antiperoxidase method and an avidin-biotin complex method for studying polypeptide hormones with radioimmunoassay antibodies.

  1981cited by this paper
• Copyright © American Society for Investigative Pathology Short Communication Expression of Cytokeratins 17 and 5 Identifies a Group of Breast Carcinomas with Poor Clinical Outcome

  year unknowninfluential reference

• Expression of p53 protein product in triple negative breast cancers and relation with clinical and histopathological parameters.

  2015cites this paper
• Expression of p53 Protein Product in Triple Negative Breast Cancers and Relation with Clinical and Histopathological Parameters/ Експресија На Р53 Протеинскиот Продукт Кај Тројно Негативните Карциноми На Дојка Во Сооднос Со Клиничките И Хистопатолошките Параметри

  2015cites this paper
• Further immunohistochemical findings on triple-negative breast cancer

  2013cites this paper